2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
PMID:29763144
Hodgkin Lymphoma (Nursing).
Kaseb H, Babiker HM, Doerr C.
2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
PMID:33760566
Metachronous mixed cellularity classical Hodgkin's lymphoma and T-cell leukemia/lymphoma: A case report.
Dong Y, Deng LJ, Li MM.
World J Clin Cases. 2021 Sep 26;9(27):8177-8185. doi: 10.12998/wjcc.v9.i27.8177.
PMID:34621878
Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study.
Papoudou-Bai A, Koumpis E, Karpathiou G, Hatzimichael E, Kanavaros P.
Diseases. 2024 Feb 29;12(3):51. doi: 10.3390/diseases12030051.
PMID:38534975
Inflammatory microenvironment in classical Hodgkin's lymphoma with special stress on mast cells.
Ribatti D, Tamma R, Annese T, Ingravallo G, Specchia G.
Front Oncol. 2022 Oct 13;12:964573. doi: 10.3389/fonc.2022.964573. eCollection 2022.
PMID:36313712
Immune Checkpoint Inhibitors for Classical Hodgkin Lymphoma in Brentuximab Vedotin-naive Patients: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines.
Williams D, Gray C, Picheca L.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 21.
PMID:31503428
Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases.
Mirzamani N, Zhang X, Brody J, Spitzer SG, Sen F, Hsu P.